Newsroom

SYDNEY--(BUSINESS WIRE)--Spending on technology services in Asia Pacific grew by double digits in Q1, powered by AI-driven demand for cloud infrastructure services: ISG Index....

SAN JOSE, Calif.--(BUSINESS WIRE)--Western Digital Corporation (Nasdaq: WDC) today announced management participation in the following upcoming investor conferences: Event: Barclays 18th Annual Americas Select Conference 2026 Date: Tuesday, May 5, 2026, at 6:15 a.m. PT / 9:15 a.m. ET Event: J.P. Morgan 2026 Global Technology, Media and Communications Conference Date: Monday, May 18, 2026, at 1:10 p.m. PT / 4:10 p.m. ET Event: Bank of America Global Technology Conference 2026 Date: Tuesday, June...

美国圣地亚哥--(BUSINESS WIRE)--(美国商业资讯)-- 冠科生物为JSR 生命科学集团旗下子公司，是一家全球领先的医药研发合同研究组织（CRO）。其今日宣布，与顶尖虚拟生物学企业 Turbine 建立战略合作伙伴关系。双方将整合 Turbine 的计算机虚拟筛选技术与冠科生物 HUB 类器官肿瘤检测体系，联合推动转化肿瘤学研究发展，并构建贯通式研发流程，让科研人员高效打通 “假设 — 验证” 全链条，大幅提升研发效率。 Turbine 虚拟检测技术可针对数千个生物样本、数百种药物，模拟其生物学应答过程，生成精准预测结果，助力研究人员高效筛选并排序药物靶点、治疗方案及联合用药策略。结合冠科生物数百种肿瘤类器官模型的多组学数据与药物响应数据，将进一步提升预测可靠性。双方携手打造 “预测 — 验证” 闭环研发模式，在提高预测准确度、降低实验成本的同时，显著增强生物学相关性与临床转化可信度。 依托 Turbine 的计算机模拟预测，研究人员可利用冠科生物的肿瘤类器官检测体系，对优选研发方案开展实验验证，从而优化实验设计、降低研发成本、缩短开发周期。 这一模式可帮助科研团队更早获...

米国サンディエゴ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 世界的な受託研究機関（CRO）であり、JSRライフサイエンスグループ傘下のCrown Bioscienceは本日、バーチャルバイオロジー分野のリーディングカンパニーであるTurbine社との戦略的パートナーシップを発表しました。このパートナーシップは、Turbine社のin silico仮想アッセイと、HUBオルガノイド技術に基づくCrown Bioscienceの腫瘍オルガノイドアッセイを統合することで、トランスレーショナルオンコロジー研究を推進することを目的としています。この連携により、研究者が仮説から検証へとより効率的に移行できる、連携したワークフローが構築されます。 Turbine社のバーチャルアッセイは、数千もの生物学的サンプルと数百種類の薬剤に対する生物学的反応をシミュレートし、標的、治療法、および併用療法を特定して優先順位付けするための予測情報を提供します。この予測は、Crown Bioscience社が保有する数百もの腫瘍オルガノイドモデルから得られるマルチモーダルデータと薬剤反応データを...

TUCSON, Ariz.--(BUSINESS WIRE)--Rompower Energy Systems Inc. today announced its participation at PCIM Europe 2026, where it will deliver three advanced technical seminars in Nuremberg, Germany. The first seminar, entitled “Magnetics for High Power in Artificial Intelligence and Modern Automotive Applications” Seminar Details This seminar will focus on the latest advancements in magnetic technologies enabling next-generation power conversion systems. Emphasis will be placed on emerging AI serve...

SAN RAMON, Calif.--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), un partner di spicco nella trasformazione dell’intelligenza artificiale per le aziende Fortune 1000, oggi ha annunciato l’implementazione riuscita di un’esperienza di shopping digitale iper personalizzata per Galeries Lafayette, gli iconici grandi magazzini francesi. Integrando Google Vertex AI Search for Commerce con la piattaforma proprietaria Grid Dynamics Merchandising Experience Platform (MXP...

SAN RAMÓN, California--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), socio líder en transformación impulsada por IA para empresas de la lista Fortune 1000, anunció hoy la implementación exitosa de una estrategia de compra digital hiperpersonalizada para Galeries Lafayette, la emblemática cadena francesa de tiendas. Al integrar Vertex AI Search for Commerce, la plataforma de búsqueda de Google, con la plataforma propia de Grid Dynamics, Merchandising Experience...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new data from the positive Phase III FENhance 1 and 2 studies, which met their primary endpoint. The studies showed that fenebrutinib, an investigational non-covalent Bruton’s tyrosine kinase (BTK) inhibitor, reduced the annualized relapse rate (ARR) by 51.1% (p<0.001) in FENhance 1 and 58.5% (p<0.0001) in FENhance 2 compared with teriflunomide in patients wit...

BEIJING--(BUSINESS WIRE)--Horse Powertrain, a global leader in innovative and low-emission powertrain systems, has revealed the HORSE W30 – the company’s first production-ready V6 engine – ahead of the Beijing Auto Show 2026. The HORSE W30 marks a first for Horse Powertrain, in transferring its expertise in developing optimized three- and four-cylinder engines into the V6 category. By deploying its expertise in this way, Horse Powertrain has developed the lightest V6 on the market and created a...

OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceuticals Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced two upcoming presentations at the 2026 American Society of Clinical Oncology (ASCO) annual meeting to be held in Chicago, Illinois, from May 29 to June 2, 2026. ONO-4578 Monday, June 1, 2026, 9:45 am to 12:45 pm CT, Oral Presentation Abstract Number: 4007 Title: ONO-4578 combined with nivolumab and chemotherapy as first-line treatment for patients w...